Plain-English translation of NCT04179929 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a personalized chemotherapy approach for adults with acute lymphoblastic leukemia (a blood cancer). All patients start with the same four-drug combination—vincristine, prednisone, pegylated asparaginase, and daunorubicin—but the treatment plan after that depends on how well your cancer responds and your genetic profile. Some patients may move on to stem cell transplantation if needed.
This trial exists because doctors want to find the best way to treat this type of blood cancer in adults by tailoring treatment intensity to each patient's response and genetic factors, rather than using a one-size-fits-all approach.
You likely qualify if…
You likely don't qualify if…
You would first receive four chemotherapy drugs intravenously as your initial treatment. Depending on how well your cancer responds—measured by blood tests looking for remaining cancer cells—you may receive additional chemotherapy blocks, or you may be referred for a stem cell transplant. The study involves regular hospital or clinic visits for infusions, blood draws, and monitoring over several months to more than a year, with your exact schedule depending on which treatment path your doctor recommends for you.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Spain